Bagante, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 4.384
EU - Europa 4.292
AS - Asia 3.262
SA - Sud America 482
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 12.484
Nazione #
US - Stati Uniti d'America 4.323
SG - Singapore 1.322
CN - Cina 1.196
GB - Regno Unito 1.185
IT - Italia 692
BR - Brasile 437
DE - Germania 434
HK - Hong Kong 423
IE - Irlanda 405
RU - Federazione Russa 401
SE - Svezia 359
FR - Francia 349
FI - Finlandia 195
UA - Ucraina 94
TR - Turchia 75
KR - Corea 65
CA - Canada 35
NL - Olanda 34
AT - Austria 33
VN - Vietnam 30
IN - India 27
BE - Belgio 21
IQ - Iraq 18
JP - Giappone 17
AR - Argentina 16
CZ - Repubblica Ceca 16
BD - Bangladesh 14
CH - Svizzera 13
ES - Italia 13
MA - Marocco 13
PK - Pakistan 12
MX - Messico 11
RO - Romania 9
TG - Togo 9
ID - Indonesia 8
UZ - Uzbekistan 8
CO - Colombia 7
EC - Ecuador 7
EU - Europa 7
ZA - Sudafrica 7
AZ - Azerbaigian 6
PL - Polonia 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
EG - Egitto 5
LT - Lituania 5
SA - Arabia Saudita 5
SC - Seychelles 5
CL - Cile 4
EE - Estonia 4
NP - Nepal 4
PE - Perù 4
BH - Bahrain 3
IL - Israele 3
JM - Giamaica 3
KZ - Kazakistan 3
NO - Norvegia 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
BB - Barbados 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HN - Honduras 2
HU - Ungheria 2
KE - Kenya 2
KG - Kirghizistan 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
MY - Malesia 2
PY - Paraguay 2
RS - Serbia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
MW - Malawi 1
NC - Nuova Caledonia 1
NG - Nigeria 1
NR - Nauru 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
Totale 12.478
Città #
Southend 1.100
Chandler 704
Singapore 619
Hong Kong 423
Dublin 403
Jacksonville 403
Dallas 332
Woodbridge 320
Beijing 259
Ashburn 251
Munich 161
Ann Arbor 160
Houston 156
Lawrence 150
Princeton 150
Verona 137
Wilmington 135
The Dalles 116
Helsinki 105
Nanjing 94
Jinan 91
Columbus 81
New York 80
Shenyang 68
Tianjin 49
Sindelfingen 46
Hebei 42
Santa Clara 40
Milan 38
Ningbo 36
Nanchang 34
Los Angeles 33
Seattle 32
Changsha 31
Council Bluffs 31
Redwood City 31
São Paulo 30
Norwalk 28
Rome 28
Turku 27
Zhengzhou 27
Falls Church 26
Taizhou 26
Boardman 24
Guangzhou 21
Haikou 21
Nuremberg 21
Hangzhou 20
Washington 20
Moscow 19
Seoul 19
Vienna 19
London 18
San Francisco 18
Brussels 17
Cambridge 17
Taiyuan 17
Jiaxing 16
Tokyo 16
Brno 15
Bologna 14
Dong Ket 13
Frankfurt am Main 13
Redmond 13
Stockholm 13
Lanzhou 12
Toronto 12
Brasília 11
Campinas 11
Chicago 11
Zurich 11
Belo Horizonte 10
Düsseldorf 10
Fairfield 10
Cagliari 9
Lomé 9
Atlanta 8
Brooklyn 8
Fuzhou 8
Lancaster 8
Lappeenranta 8
Ottawa 8
Rio de Janeiro 8
Bogotá 7
Dongguan 7
Madrid 7
Napoli 7
San Diego 7
Tashkent 7
Baghdad 6
Baku 6
Caxias do Sul 6
Chennai 6
Esslingen am Neckar 6
Florence 6
Jyväskylä 6
Piracicaba 6
Shanghai 6
Amsterdam 5
Boston 5
Totale 7.795
Nome #
Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma 449
'Recurrence of cholangiocarcinoma after surgical treatment: an analysis of modes of occurrence, risk factors, and results of treatment. 261
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 208
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 207
Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer 171
A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC) 156
Impact of age on short-term outcomes of liver surgery: Lessons learned in 10-years' experience in a tertiary referral hepato-pancreato-biliary center 143
Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis 141
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 141
development of two nomograms for predicting major adverse cardiac events and death in patients admitted to the emergency department with chest pain 140
Prognostic value of portal hypertension after surgical resection of HCC in cirrhotic patients 138
Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma. 137
Pancreatic resections in patients who refuse blood transfusions. The application of a perioperative protocol for a true bloodless surgery 133
Hepatolithiasis-associated cholangiocarcinoma: results from a multi-institutional national database on a case series of 23 patients. 129
Usefulness of contrast-enhanced intraoperative ultrasonography (CE-IOUS) in patients with colorectal liver metastases after preoperative chemotherapy. 127
Patterns and prognostic significance of lymph-node dissection for surgical treatment of peri-hilar and intrahepatic cholangiocarcinoma 126
A Novel Prognostic Score based on Serum Alpha-Fetoprotein, Number of Nodules, and MYC Gene Status Predicts Prognosis of Patients after Liver Resection for Hepatocellular Carcinoma 118
What is the most accurate lymph node staging method for perihilar cholangiocarcinoma? Comparison of UICC/AJCC pN stage, number of metastatic lymph nodes, lymph node ratio, and log odds of metastatic lymph nodes 116
Tu1730 A Clinical Score Predicting the Occurence of Liver-Related Complications Following Hepatectomy 115
Assessment of the Lymph Node Status in Patients Undergoing Liver Resection for Intrahepatic Cholangiocarcinoma: the New Eighth Edition AJCC Staging System 114
Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data 114
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 113
Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence 111
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 110
Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma 107
Surgical Resection Versus Local Ablation for HCC on Cirrhosis: Results from a Propensity Case-Matched Study 106
Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas 105
Pancreaticoduodenectomy with venous resection and reconstruction: current surgical techniques and associated postoperative imaging findings 104
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 103
Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer 102
Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme 102
Defining Post Hepatectomy Liver Insufficiency: Where do We stand? 101
Cholangiocarcinoma risk factors and the potential role of aspirin 101
A multi-institutional analysis of elderly patients undergoing a liver resection for intrahepatic cholangiocarcinoma 98
Integrating Clinical Data and Molecular Profiling of Hepato-Pancreato-Biliary Cancers: a Surgical-pathological Approach 97
Postoperative Omental Infarct After Distal Pancreatectomy: Appearance, Etiology Management, and Review of Literature 97
Liver Resection for Breast Cancer Liver Metastases A Cost-utility Analysis 96
Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis 96
Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma 95
The START nomogram for individualized prediction of the probability of unfavorable outcome after intravenous thrombolysis for stroke 94
The albumin-bilirubin score stratifies the outcomes of Child-Pugh class A patients after resection of hepatocellular carcinoma 94
Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma 93
Validation of a Nomogram to Predict the Risk of Perioperative Blood Transfusion for Liver Resection 92
Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis 92
Primary liver cancer: Prognostic factors and predictive response to therapy 90
The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma 89
Patterns of Distribution of Hepatic Nodules (Single, Satellites or Multifocal) in Intrahepatic Cholangiocarcinoma: Prognostic Impact After Surgery 88
Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis 87
Neuroendocrine liver metastasis: The chance to be cured after liver surgery 86
Surgical Management of Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Impact of Lymphadenectomy on Peri-Operative Outcomes 86
Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: A regret-based decision curves analysis 86
Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy 86
Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study 85
Minimally Invasive vs. Open Hepatectomy: a Comparative Analysis of the National Surgical Quality Improvement Program Database 84
Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma 83
Impact of Delta Hemoglobin on Provider Transfusion Practices and Post-operative Morbidity Among Patients Undergoing Liver and Pancreatic Surgery 83
Central Pancreatectomy: from Open to Minimally Invasive 83
Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification 83
Role of inflammatory and immune-nutritional prognostic markers in patients undergoing surgical resection for biliary tract cancers 83
Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma 81
Synergistic Effects of Perioperative Complications on 30-Day Mortality Following Hepatopancreatic Surgery 81
Comparison of the 7th and 8th editions of the American Joint Committee on Cancer Staging Systems for perihilar cholangiocarcinoma 81
Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment 80
Complications after liver surgery: a benchmark analysis 80
Use of Machine Learning for Prediction of Patient Risk of Postoperative Complications After Liver, Pancreatic, and Colorectal Surgery 79
Simultaneous approach for patients with synchronous colon and rectal liver metastases: Impact of site of primary on postoperative and oncological outcomes 79
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 79
Outcomes of vascular resection associated with curative intent hepatectomy for intrahepatic cholangiocarcinoma 77
The Impact of Discharge Timing on Readmission Following Hepatopancreatobiliary Surgery: a Nationwide Readmission Database Analysis 76
Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival 76
Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection 76
Quality of life after treatment of neuroendocrine liver metastasis 76
Multigene mutational profiling of biliary tract cancer is related to the pattern of recurrence in surgically resected patients 76
Pancreatic Fistula and Delayed Gastric Emptying After Pancreatectomy: Where do We Stand? 75
Variation in Medicare Payments and Reimbursement Rates for Hepatopancreatic Surgery Based on Quality: Is There a Financial Incentive for High-Quality Hospitals? 74
Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy 73
Nomogram to predict perioperative blood transfusion for hepatopancreaticobiliary and colorectal surgery 72
The Cost of Failure: Assessing the Cost-Effectiveness of Rescuing Patients from Major Complications After Liver Resection Using the National Inpatient Sample 72
Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent 71
Surgical Procedures in Health Professional Shortage Areas: Impact of a Surgical Incentive Payment Plan 71
The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional Study 70
ASO Author Reflections: Re-resection of Positive Bile Duct Margin for Hilar Cholangiocarcinoma 70
Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi-institutional analysis 69
Liver transplantation in patients with liver metastases from neuroendocrine tumors 69
Preoperative Risk Score and Prediction of Long-Term Outcomes after Hepatectomy for Intrahepatic Cholangiocarcinoma 68
The Impact of Dedicated Cancer Centers on Outcomes Among Medicare Beneficiaries Undergoing Liver and Pancreatic Cancer Surgery 68
A Novel Machine-Learning Approach to Predict Recurrence After Resection of Colorectal Liver Metastases 68
Liver Resection for Neuroendocrine Tumor Liver Metastases Within Milan Criteria for Liver Transplantation 67
A machine learning analysis of difficulty scoring systems for laparoscopic liver surgery 65
Role of Lymph Node Dissection in Small (≤ 3 cm) Intrahepatic Cholangiocarcinoma 65
Synergistic Impact of Alpha-Fetoprotein and Tumor Burden on Long-Term Outcomes Following Curative-Intent Resection of Hepatocellular Carcinoma 63
Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery 63
A Comparison of Open and Minimally Invasive Surgery for Hepatic and Pancreatic Resections Among the Medicare Population 63
Patterns of gene mutations in bile duct cancers: is it time to overcome the anatomical classification? 63
Perioperative use of blood products is associated with risk of morbidity and mortality after surgery 63
ASO Author Reflections: Minimally Invasive Surgery for Hepatocellular Carcinoma in the Setting of Portal Vein Hypertension 63
Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients 63
Impact of histological subtype on the prognosis of patients undergoing surgery for colon cancer 60
Pre-operative Sarcopenia Identifies Patients at Risk for Poor Survival After Resection of Biliary Tract Cancers 60
The impact of a malignant diagnosis on the pattern and outcome of readmission after liver and pancreatic surgery: An analysis of the nationwide readmissions database 60
Totale 9.880
Categoria #
all - tutte 54.864
article - articoli 51.632
book - libri 0
conference - conferenze 2.146
curatela - curatele 0
other - altro 380
patent - brevetti 0
selected - selezionate 0
volume - volumi 706
Totale 109.728


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021894 0 0 32 177 183 145 18 43 79 30 143 44
2021/2022917 106 165 25 63 28 32 24 75 40 31 43 285
2022/20232.317 181 231 241 359 171 609 26 124 261 20 66 28
2023/20241.129 54 93 105 103 159 195 43 112 6 51 140 68
2024/20253.337 185 217 112 560 213 177 166 201 447 224 277 558
2025/20261.085 691 377 17 0 0 0 0 0 0 0 0 0
Totale 12.695